Free Trial

Camtek (CAMT) Competitors

Camtek logo
$87.52 +5.48 (+6.68%)
Closing price 04:00 PM Eastern
Extended Trading
$88.76 +1.24 (+1.42%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CAMT vs. RVTY, AVTR, NVMI, BIO.B, VNT, MIR, ST, TXG, TRNS, and ALNT

Should you be buying Camtek stock or one of its competitors? The main competitors of Camtek include Revvity (RVTY), Avantor (AVTR), Nova (NVMI), Bio-Rad Laboratories (BIO.B), Vontier (VNT), Mirion Technologies (MIR), Sensata Technologies (ST), 10x Genomics (TXG), Transcat (TRNS), and Allient (ALNT). These companies are all part of the "measuring and control equipment" industry.

Camtek vs. Its Competitors

Camtek (NASDAQ:CAMT) and Revvity (NYSE:RVTY) are both measuring and control equipment companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Camtek currently has a consensus price target of $89.70, indicating a potential upside of 2.49%. Revvity has a consensus price target of $123.64, indicating a potential upside of 22.54%. Given Revvity's higher possible upside, analysts clearly believe Revvity is more favorable than Camtek.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Camtek
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.00
Revvity
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.80

Camtek has a net margin of 28.40% compared to Revvity's net margin of 10.35%. Camtek's return on equity of 24.57% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Camtek28.40% 24.57% 15.09%
Revvity 10.35%7.73%4.72%

Camtek has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, Revvity has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500.

In the previous week, Revvity had 5 more articles in the media than Camtek. MarketBeat recorded 13 mentions for Revvity and 8 mentions for Camtek. Camtek's average media sentiment score of 0.99 beat Revvity's score of -0.07 indicating that Camtek is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Camtek
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Revvity
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

41.9% of Camtek shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 79.4% of Camtek shares are owned by insiders. Comparatively, 0.7% of Revvity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Revvity has higher revenue and earnings than Camtek. Camtek is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Camtek$429.23M9.30$118.51M$2.6133.53
Revvity$2.76B4.32$270.39M$2.3542.94

Summary

Camtek beats Revvity on 9 of the 16 factors compared between the two stocks.

Get Camtek News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAMT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAMT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAMT vs. The Competition

MetricCamtekELEC MSRNG INST IndustryComputer SectorNASDAQ Exchange
Market Cap$3.74B$14.43B$27.19B$8.87B
Dividend YieldN/A0.28%3.15%4.10%
P/E Ratio33.5325.3236.0419.90
Price / Sales9.305.672,037.69113.66
Price / Cash27.5022.6637.6556.90
Price / Book7.245.897.055.38
Net Income$118.51M$303.71M$763.02M$248.50M
7 Day Performance6.61%4.23%3.10%2.97%
1 Month Performance31.00%41.68%6.51%6.02%
1 Year Performance-31.27%27.16%52,212.28%20.39%

Camtek Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAMT
Camtek
3.0059 of 5 stars
$87.52
+6.7%
$89.70
+2.5%
-35.8%$3.74B$429.23M33.53400Analyst Forecast
Gap Up
RVTY
Revvity
3.7443 of 5 stars
$95.01
+0.0%
$125.64
+32.2%
-3.9%$11.20B$2.76B40.4311,000
AVTR
Avantor
4.9845 of 5 stars
$13.45
-0.9%
$18.88
+40.3%
-33.0%$9.17B$6.78B12.9313,500Positive News
NVMI
Nova
2.0267 of 5 stars
$234.10
+1.3%
$277.00
+18.3%
+15.3%$6.88B$672.40M35.364,149Positive News
BIO.B
Bio-Rad Laboratories
N/A$250.08
flat
N/A-11.8%$6.80B$2.57B-3.288,200
VNT
Vontier
3.6268 of 5 stars
$36.28
+1.5%
$44.83
+23.6%
-1.1%$5.37B$2.96B14.758,000
MIR
Mirion Technologies
0.7315 of 5 stars
$20.33
+3.5%
$18.75
-7.8%
+93.2%$4.72B$860.80M-338.832,860High Trading Volume
ST
Sensata Technologies
4.222 of 5 stars
$28.63
+1.3%
$34.08
+19.0%
-16.7%$4.19B$3.93B35.3519,000News Coverage
Analyst Forecast
TXG
10x Genomics
4.645 of 5 stars
$10.79
-0.2%
$15.81
+46.5%
-35.1%$1.33B$610.78M-8.301,240
TRNS
Transcat
2.9649 of 5 stars
$80.27
-0.3%
$114.00
+42.0%
-26.9%$748.12M$278.42M51.461,245
ALNT
Allient
2.674 of 5 stars
$34.61
+2.6%
$31.00
-10.4%
+50.5%$585.95M$529.97M58.662,525News Coverage

Related Companies and Tools


This page (NASDAQ:CAMT) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners